IFNA1 and COVID-19: Our findings that anti‐IFN‐β NAB are rarely detected in COVID‐19 individuals is in agreement with Bastard et al., who found only 2 out of 19 COVID‐19 patients with anti‐IFN‐α auto‐Abs had anti‐IFN‐β antibodies [8].